logo
Plus   Neg
Share

Short-Term Investor Stock RH Gains 34.1%

The stock, RH (RH), featured on our 'Short-Term Investor' on September 11, 2019, at an opening price of $155.35. On November 29, 2019, the stock touched a new 52-week high of $208.33, representing a gain of 34.1%. The stock closed yesterday's trade at $205.62.

A regulatory filing on Nov. 15, revealed that Buffett’s Berkshire Hathaway had bought $206 million shares of RH in the third quarter.

Why we published this stock?

RH raised its fiscal 2019 guidance, while reporting upbeat Q2 results.

FY19 Guidance

The company then expected fiscal 2019 adjusted revenues in the range of $2.680 billion - $2.694 billion versus the prior issued range of $2.658 billion - $2.674 billion. RH raised its fiscal 2019 adjusted net income outlook range to $246.9 million - $252.3 million, or $10.53 - $10.76 per share from the previously communicated range of $213.3 million - $223.8 million, or $9.08 - $9.52 per share.

Eighteen Wall Street analysts then had a consensus earnings estimate of $9.44 per share and revenue of $2.67 billion for fiscal 2019.

Q2 Results

The company's Q2 GAAP net income was $63.8 million or $2.86 per share compared to $62.9 million or $2.29 per share last year.

Adjusted net income for the quarter was $71.4 million or $3.20 per share versus $54.5 million or $2.01 per share a year ago.

Analysts polled by Thomson Reuters expected earnings of $2.70 per share for the quarter. Analysts' estimate typically exclude certain special items.

Net revenues for the quarter increased 10.3% to $706.5 million from the previous year's revenue of $640.8 million.

Free Sign Up
Free Sign Up

Short-Term Investor Top Perfomers
Pub. DateCompany% Gain
01/10/2018 TNDM + 696.14
05/08/2018 TREX + 211.39
05/17/2016 MIME + 207.12
01/07/2016 QUAD + 198.90
05/24/2016 EXEL + 185.08
08/08/2019 ACMR + 184.92
01/30/2015 CORT + 161.51
01/19/2017 TAL + 149.84
08/20/2015 MSG + 141.43
01/09/2017 EXAS + 140.34
Complete Performance
Under the Radar Top Perfomers
Pub. DateCompany% Gain
04/27/2020 MDGS + 108.50
02/20/2013 IKNX + 99.41
08/13/2014 INGN + 98.42
11/11/2014 CYAN + 89.14
02/22/2019 BOOM + 87.02
12/11/2014 INTL + 86.33
03/07/2019 FLY + 81.83
10/23/2014 OFLX + 81.26
08/14/2014 AMOT + 79.00
02/07/2018 MHH + 78.84
09/11/2014 MSON + 78.44
Complete Performance
Emerging Biostocks Top Perfomers
Pub. DateCompany% Gain
04/19/2017 MRTX + 1576
07/17/2018 AMRN + 737
04/05/2017 MYOK + 734
10/03/2019 CNST + 552
02/11/2016 TBRA + 542
11/25/2017 CBIO + 464
09/03/2019 APLT + 437
11/03/2019 THOR + 362
09/21/2018 CCXI + 339
11/23/2017 ARGX + 302
02/05/2018 VKTX + 295
01/18/2018 ADVM + 218
06/06/2018 CSBR + 216
03/26/2020 MRNA + 216
04/06/2020 TBIO + 184
03/03/2020 OVID + 181
04/08/2019 SOLY + 170
09/10/2018 NTEC + 140
06/20/2019 ZYXI + 106
Complete Performance
Free Sign Up